Songbing He
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 6
- Peroxisome Proliferator-Activated Receptors 3
- Metabolism, Diabetes, and Cancer 2
-
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 8
- Cancer, Lipids, and Metabolism 6
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Huihui Yao (4 shared papers)Liang Sun (11 shared papers)Yizhou Yao (10 shared papers)Xinguo Zhu (8 shared papers)Daiwei Wan (10 shared papers)Qiaoming Zhi (9 shared papers)Diyuan Zhou (7 shared papers)Guoqiang Zhou (3 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (4 papers)Anti-Cancer Agents in Medicinal Chemistry (3 papers)Tumor Biology (2 papers)EBioMedicine (2 papers)Clinical & Translational Oncology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Songbing He
34 papers receiving 951 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 519
- Molecular Biology 736
- Oncology 194
- Cell Biology 75
- Pulmonary and Respiratory Medicine 112
Countries citing papers authored by Songbing He
This map shows the geographic impact of Songbing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Songbing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Songbing He more than expected).
Fields of papers citing papers by Songbing He
This network shows the impact of papers produced by Songbing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Songbing He. The network helps show where Songbing He may publish in the future.
Co-authors
The 25 scholars most cited alongside Songbing He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 65 | |
| 2 | 2021 | 65 | |
| 3 | 2016 | 63 | |
| 4 | 2021 | 54 | |
| 5 | 2019 | 49 | |
| 6 | 2019 | 48 | |
| 7 | 2018 | 45 | |
| 8 | 2019 | 44 | |
| 9 | 2016 | 43 | |
| 10 | 2013 | 40 | |
| 11 | 2013 | 39 | |
| 12 | 2019 | 38 | |
| 13 | 2020 | 32 | |
| 14 | 2017 | 31 | |
| 15 | 2014 | 30 | |
| 16 | 2014 | 27 | |
| 17 | 2019 | 23 | |
| 18 | 2018 | 23 | |
| 19 | 2016 | 22 | |
| 20 | 2018 | 22 |
About Songbing He
Songbing He is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Immunology, having authored 34 papers that have together received 957 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers), Cancer, Lipids, and Metabolism (6 papers), Circular RNAs in diseases (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Cancer Research (519 citations), Molecular Biology (736 citations), Oncology (194 citations), Cell Biology (75 citations) and Pulmonary and Respiratory Medicine (112 citations). Songbing He has collaborated with scholars based in China and United States. Frequent co-authors include Huihui Yao, Liang Sun, Yizhou Yao, Xinguo Zhu, Daiwei Wan, Qiaoming Zhi, Diyuan Zhou, Guoqiang Zhou, Xinguo Zhu and Shiduo Song. Their work appears in journals such as Biomedicine & Pharmacotherapy, Anti-Cancer Agents in Medicinal Chemistry, Tumor Biology, EBioMedicine and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.